Novozymes reports 11% sales growth for bioenergy segment in 2021

February 1, 2022

BY Erin Voegele

Novozymes released fourth quarter financial results on Feb. 1, reporting bioenergy sales were up 10 percent for the three-month period and 11 percent for the full year 2021. The increase was primarily attributed to the recovery of the U.S. ethanol market.

The company reported that U.S. ethanol production gradually recovered in 2021 following a decline in production and use in 2020 caused by the COVID-19 pandemic. Despite the recovery, U.S. ethanol production in 2021 was still lower than 2019 production. “The main factors behind the strong performance in bioenergy were the recovery of the U.S. ethanol industry in combination with growth from innovation, capacity expansion of corn-based ethanol production in Latin America, and market penetration with enzymatic solutions for biodiesel production,” Novozymes said its fourth quarter report. For the fourth quarter, bioenergy sales also benefited from very high crush margins for U.S. ethanol production, which led to higher production and increased demand for Novozymes’ solutions, the company added.

Advertisement

Bioenergy sales accounted for 18 percent of Novozymes’ total sales last year. Household care accounted for 32 percent of sales, with a 1 percent decline in sales for 2021. Food, beverages and human health accounted for 23 percent of sales, with 14 percent sales growth last year, grain and tech processing accounted for 15 percent of 2021 sales and achieved 13 percent growth, while agriculture, animal health and nutrition accounted for 12 percent of 2021 sales, with sales flat with 2020. Overall, Novozymes reported sales were up 6 percent company-wide last year.

Moving into 2022, Novozymes said the additional sales growth for the bioenergy segment is expected to be driven by the continued recovery in U.S. ethanol production, market penetration enabled by innovation, capacity expansion of corn-based ethanol production in Latin America, and market penetration with enzymatic solutions for biodiesel production.

Advertisement

Novozymes said it currently expects 2022 sales growth for the bioenergy segment to be in the low-to-mid single digits. The company attributed the relatively broad range of expected growth to uncertainties related to the pandemic and volatile market conditions. The mid-point range of that forecast assumes moderate growth in U.S. ethanol production this year with full-year volume still slightly below 2019 production levels.

 

 

Related Stories

Ethanol Producer Magazine announced this week the six companies selected to pitch to a group of angel investors and venture capital firms at the International Fuel Ethanol Workshop & Expo, taking place June 9-11, 2025, in Omaha, Nebraska.

Read More

Ethanol Producer Magazine has announced the keynote speakers for the 2025 International Fuel Ethanol Workshop & Expo (FEW) being held June 9-11, 2025, at the CHI Health Center in Omaha, Nebraska. The general session will take place June 10.

Read More

The U.S. exported 15,050.4 metric tons of biodiesel and biodiesel blends of B30 or greater in March, according to data released by the USDA Foreign Agricultural Service on May 6. Biodiesel imports were at 14,991.9 metric tons for the month.

Read More

The Canadian International Trade Tribunal on May 5 announced that a preliminary investigation launched earlier this year did not find evidence that imports of U.S. renewable diesel are causing harm to Canada’s domestic renewable diesel industry.

Read More

Marathon Petroleum Corp. on May 6 reported improved first quarter EBITDA for its renewable diesel segment on increased utilization of its facilities, particularly the Martinez biorefinery in California, and higher margins.

Read More

Upcoming Events

Sign up for our e-newsletter!

Advertisement

Advertisement